Although data shown here are based on genomic analysis of immortalized cell lines and therefore may not reflect clinical TNBC populations, RICTOR amplification has been shown to co-occur with PI3K pathway alterations in TNBC and other cancers at a relatively high frequency (48, 49). Here, RICTOR is linked to cancer.